Roche Holding AG Ordered to Pay $25 Million to Accutane User
Bloomberg -- Roche Holding AG, the Swiss drugmaker, must pay $25.16 million in damages to a former user of its Accutane drug who blamed the acne medicine for his inflammatory bowel disease, a New Jersey jury ruled.